While AI excels at screening vast compound libraries for potential drug candidates, it cannot overcome the ultimate bottleneck: the messy, complex, and poorly documented reality of human biology. The need for physical clinical trials remains the fundamental constraint on medical progress.

Andrej Karpathy's 'Software 2.0' framework posits that AI automates tasks that are easily *verifiable*. This explains the 'jagged frontier' of AI progress: fields like math and code, where correctness is verifiable, advance rapidly. In contrast, creative and strategic tasks, where success is subjective and hard to verify, lag significantly behind.

Judgment Labs CEO Alex Shan argues that AI agents will first dominate domains with easily verifiable results, like coding, where a solution's correctness can be quickly checked. Progress will be slower in non-verifiable fields like law or complex drug discovery, where feedback loops are long and ambiguous.

AI can produce scientific claims and codebases thousands of times faster than humans. However, the meticulous work of validating these outputs remains a human task. This growing gap between generation and verification could create a backlog of unproven ideas, slowing true scientific advancement.

Unlike coding, where AI models get immediate feedback on whether code runs, drug development faces immense delays. A biological hypothesis can take a decade and hundreds of millions of dollars to test in the clinic. This lack of rapid validation checkpoints is a core obstacle for AI's ability to learn and reliably improve drug target selection.

Demis Hassabis identifies a key obstacle for AGI. Unlike in math or games where answers can be verified, the messy real world lacks clear success metrics. This makes it difficult for AI systems to use self-improvement loops, limiting their ability to learn and adapt outside of highly structured domains.

Unlike math or code with cheap, fast rewards, clinically valuable biology problems lack easily verifiable ground truths. This makes it difficult to create the rapid reinforcement learning loops that drive explosive AI progress in other fields.

AI models improve dramatically in domains with objective feedback, like coding (unit tests) or science (lab results). Progress is slower in subjective fields like creative writing where feedback is opinion-based, explaining the uneven impact of AI across different types of knowledge work.

AI can generate vast amounts of content, but its value is limited by our ability to verify its accuracy. This is fast for visual outputs (images, UI) where our eyes instantly spot flaws, but slow and difficult for abstract domains like back-end code, math, or financial data, which require deep expertise to validate.